Business Context and Reporting Period
Company: Xtant Medical Holdings, Inc. (XTNT)
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2025
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2025.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed figures. Consequently, specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this filing text.
Non-GAAP Measure Defined: The Company utilizes Non-GAAP Adjusted EBITDA to assess core operational performance. This metric is defined as net income (loss) from operations before depreciation, amortization, interest, and taxes, with further adjustments to exclude:
- Separation-related expenses
- Non-cash compensation
- Divestiture/acquisition-related expenses
- Acquisition-related fair value adjustments
- Unrealized foreign currency translation gain or loss
Material Changes and Strategic Context
The filing highlights specific strategic activities impacting financial reporting:
- Pending Divestiture: The Company is in the process of divesting its non-core Coflex/CoFix assets and its international hardware business.
- Acquisitions: The Company notes ongoing integration of acquisitions.
- Expense Classification: Legal, accounting, and transition fees related to the divestiture and acquisitions are excluded from Non-GAAP Adjusted EBITDA as they are not considered normal, recurring cash operating expenses.
Guidance, Outlook, and Risks
Management Commentary: Management states that Non-GAAP Adjusted EBITDA facilitates internal comparisons by factoring out charges not related to regular, ongoing business, such as non-cash charges and unpredictable large charges. It is used for budgeting, resource allocation, and investment decisions in sales, marketing, and R&D.
Risks and Limitations: The filing includes standard disclaimers that Non-GAAP measures are not in accordance with GAAP, may differ from measures used by other companies, and should only be used in conjunction with GAAP measures. The text does not provide specific forward-looking guidance or numerical outlooks.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual numerical values of revenue, net income, and cash flow for the three and nine months ended September 30, 2025.
- Verify the reconciliation table between Net Income and Non-GAAP Adjusted EBITDA to understand the magnitude of excluded items (e.g., separation costs, non-cash comp).
- Confirm the status and timeline of the pending divestiture of Coflex/CoFix assets and the international hardware business.
- Assess the impact of unrealized foreign currency translation gains/losses on reported results.